Working Group of the Microbiological Reporting System of Catalonia
Working Group of the Epidemiological Surveillance Network of Catalonia
[Ciruela P] Agència de Salut Pública de Catalunya (ASPCAT), Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. [Vilaró M, Soldevilla N, Domínguez A] CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Departament de Medicina, Universitat de Barcelona, Barcelona, Spain. [Carmona G, Garcia T, Hernández S, Ruiz L] Agència de Salut Pública de Catalunya (ASPCAT), Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. [Jané M] Agència de Salut Pública de Catalunya (ASPCAT), Departament de Salut, Generalitat de Catalunya, Barcelona, Spain. CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Departament de Medicina, Universitat de Barcelona, Barcelona, Spain
Departament de Salut
2022-08-09T06:55:36Z
2022-08-09T06:55:36Z
2022-06-21
Microbiologia de diagnòstic; Epidemiologia; Control d'infecció; Diagnòstic molecular
Microbiología de diagnóstico; Epidemiología; Control de infección; Diagnóstico molecular
Diagnostic microbiology; Epidemiology; Infection control; Molecular diagnostics
Objectives: Invasive meningococcal disease (IMD) is an urgent notifiable disease and its early notification is essential to prevent cases. The objective of the study was to assess the sensitivity of two independent surveillance systems and to estimate the incidence of IMD. Design: We used capture-recapture model based on two independent surveillance systems, the statutory disease reporting (SDR) system and the microbiological reporting system (MRS) of the Public Health Agency of Catalonia, between 2011 and 2015. The capture-recapture analysis and 95% CIs were calculated using the Chapman formula. Multivariate vector generalised linear model was performed for adjusted estimation. Measures: The variables collected were age, sex, year of report, size of municipality (<10 000 and ≥10 000), clinical form, death, serogroup, country of birth and type of reporting centre (private and public). Results: The sensitivity of the two combined surveillance systems was 88.5% (85.0-92.0). SDR had greater sensitivity than the MRS (67.9%; 62.7-73.1 vs 64.7%; 59.4-70.0). In 2014-2015, the sensitivity of both systems was higher (80.6%; 73.2-87.9 vs 73.4%; 65.2-81.6) than in 2011-2013 (59.3%; 52.6-66.0 vs 58.3%; 51.6-65.1). In private centres, the sensitivity was higher for SDR than for MRS (100%; 100-100 vs 4.8%; -4.4-13.9). The adjusted estimate of IMD cases was lower than that obtained using the Chapman formula (279; 266-296 vs 313; 295-330). The estimated adjusted incidence of IMD was 0.7/100 000 persons-year. Conclusions: The sensitivity of enhanced surveillance through the combination of two complementary sources was higher than for the sources individually. Factors associated with under-reporting in different systems should be analysed to improve IMD surveillance.
This work was supported partially by CIBER of Epidemiology and Public Health (CIBERESP), Carlos III Health Institute and the Catalan Agency for the Management of Grants for University Research (AGAUR grant number 2017/SGR 1342). The funding sources played no part in the design of the study and collection, analysis and interpretation of data and in writing the manuscript.
Artículo
Versión publicada
Inglés
Diagnòstic molecular; Meningococcèmia - Epidemiologia; DISEASES::Infections::Bacterial Infections and Mycoses::Bacterial Infections::Central Nervous System Bacterial Infections::Meningitis, Bacterial::Meningitis, Meningococcal; Other subheadings::Other subheadings::Other subheadings::/epidemiology; HEALTH CARE::Environment and Public Health::Public Health::Public Health Practice::Communicable Disease Control::Infection Control; ENFERMEDADES::Infecciones::Infecciones Bacterianas y Micosis::Infecciones Bacterianas::Infecciones Bacterianas del Sistema Nervioso Central::Meningitis Bacterianas::Meningitis Meningocócica; Otros calificadores::Otros calificadores::Otros calificadores::/epidemiología; ATENCIÓN DE SALUD::Medio Ambiente y Salud Pública::Salud Pública::Práctica de Salud Pública::Control de Enfermedades Transmisibles::Control de Infecciones
BMJ Publishing Group
BMJ Open;12(6)
https://doi.org/10.1136/bmjopen-2021-058003
Attribution-NonCommercial-ShareAlike 4.0 International
http://creativecommons.org/licenses/by-nc-sa/4.0/